INVION LIMITED — Director's Dealing 2011

Dec 1, 2011

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Dr Michael Monsour
Date of last notice	25 November 2011
Date that director ceased to be director	29 November 2011

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

90,013 ordinary shares

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

	Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest MP Monsour Medical Practice Pty Ltd Superannuation Fund A/C> MPAMM Pty Ltd Australian Biofunds Investments Limited Director and shareholder of the entities identified above. Analytica Limited – director	Number & class of securities 2,502,922 ordinary shares and 1,490,000 share options 9,377,956 ordinary shares, 1,614,000 share options & 200,000 Performance Rights 194,280 ordinary shares 1,044,712 ordinary shares and 3,000,000 options exercisable at $1.000 each by 31 Dec 2012

Part 3 – Director’s interests in contracts

Detail of contract	n/a
Nature of interest	n/a
Name of registered holder (if issued securities)	n/a
No. and class of securities to which interest relates	n/a

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Ross Mangelsdorf
Date of last notice	25 November 2011
Date that director ceased to be director	29 November 2011

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of securities Note: Provide details of the circumstances giving rise to the relevant interest Ross Mangelsdorf Tambien Pty Ltd 2,711,706 ordinary shares and 3,150,000 Tambien Pty Ltd 31/12/2012 Manowe Pty Ltd Rossdown Investments Pty Ltd - director and beneficiary of the Super fund Analytica Limited – director

Part 3 – Director’s interests in contracts

Detail of contract	n/a
Nature of interest	n/a
Name of registered holder (if issued securities)	n/a
No. and class of securities to which interest relates	n/a

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Warren Brooks
Date of last notice	25 November 2011
Date that director ceased to be director	29 November 2011

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

See Part 2 below

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

==> picture [401 x 165] intentionally omitted <==

----- Start of picture text -----

Name of holder & nature of interest Number & class of securities
Note: Provide details of the circumstances giving rise to
the relevant interest
W Brooks Investments Pty Ltd
3,049,712 ordinary shares and 3,000,000
- director and
options exercisable at $1,00 each by 31
beneficiary of the Super fund
Dec 2012
Analytica Limited – director
----- End of picture text -----

Part 3 – Director’s interests in contracts

==> picture [406 x 157] intentionally omitted <==

----- Start of picture text -----

Detail of contract n/a
Nature of interest n/a
Name of registered holder n/a
(if issued securities)
No. and class of securities to n/a
which interest relates
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002